BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Large Growth in Short Interest

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 130,200 shares, an increase of 19.4% from the December 31st total of 109,000 shares. Based on an average daily volume of 64,600 shares, the short-interest ratio is presently 2.0 days. Currently, 2.6% of the company’s stock are short sold.

BioRestorative Therapies Trading Down 4.0 %

BRTX traded down $0.10 during trading on Monday, hitting $2.29. 11,799 shares of the company’s stock traded hands, compared to its average volume of 69,964. The company’s 50 day simple moving average is $1.70 and its two-hundred day simple moving average is $1.63. BioRestorative Therapies has a 12-month low of $1.03 and a 12-month high of $3.67. The stock has a market capitalization of $15.81 million, a price-to-earnings ratio of -1.49 and a beta of 62.64.

BioRestorative Therapies (NASDAQ:BRTX) last issued its earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.22. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The business had revenue of $0.23 million for the quarter, compared to the consensus estimate of $0.30 million. On average, equities analysts expect that BioRestorative Therapies will post -1.43 EPS for the current year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.